BACITRACIN OINTMENT 500 UNITS/G DIN 02060833
Status: Cancelled Post Market
Holder: WELLSPRING PHARMACEUTICAL CANADA CORP
Molecule: BACITRACIN (BACITRACIN ZINC)
Health Canada record
| Active ingredient(s) | BACITRACIN (BACITRACIN ZINC) 500 UNIT |
|---|---|
| Dosage form | Ointment |
| Route | Topical |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | D06AX05 BACITRACIN |
| Original market date | 30-Dec-1996 |
| Current status date | 20-Jul-2005 |
| Source | Health Canada DPD |
Establishment licence of the holder
Wellspring Pharmaceutical Canada Corp — licence 100951, currently licensed, last inspection rating C (2025-08-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BACITRACIN (BACITRACIN ZINC)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02237196 | ALBAC 110 | HUVEPHARMA EOOD | Drug Premix | BACITRACIN (BACITRACIN ZINC) 110 G | Marketed |
| 02451026 | BACITRACIN OINTMENT | SAFETEC OF AMERICA INC | Ointment | BACITRACIN (BACITRACIN ZINC) 500 UNIT | Marketed |
| 02230720 | BACIFERM 50 PREMIX | HOFFMANN-LA ROCHE LIMITED | Drug Premix | BACITRACIN (BACITRACIN ZINC) 110 G | Cancelled Post Market |
| 01986023 | BACIFERM-50 PREMIX | CYANAMID CANADA INC. | Drug Premix | BACITRACIN (BACITRACIN ZINC) 110 G | Cancelled Post Market |
| 02019299 | VETROPOLYCIN HC ONT | JANSSEN | Ointment | BACITRACIN (BACITRACIN ZINC) 400 UNIT; NEOMYCIN (NEOMYCIN SULFATE) 3.5 MG; POLYMYXIN B (POLYMYXIN B) 10000 UNIT; HYDROCORTISONE ACETATE 10 MG | Cancelled Post Market |
| 02019302 | VETROPOLYCIN ONT | JANSSEN | Ointment | BACITRACIN (BACITRACIN ZINC) 400 UNIT; NEOMYCIN (NEOMYCIN SULFATE) 3.5 MG; POLYMYXIN B (POLYMYXIN B SULFATE) 10000 UNIT | Cancelled Post Market |